RMH Holdings Limited reported a quarterly update on its action plan to resolve the auditor’s disclaimer of opinion and comply with resumption guidance.

Audit status and key outstanding items Most audit fieldwork for the 2025 financial year is substantially complete, but two bank confirmations—SGD 2.20 million with United Overseas Bank and SGD 1.80 million with DBS Bank—remain pending. These balances relate to financial guarantee liabilities aggregating SGD 4.08 million that the Group continues to recognise for the Singapore liquidated subsidiaries. Although Dr. Loh has fully repaid the default borrowings and waived recourse against the Group, the liabilities cannot be derecognised until official bank discharges are received.

Mitigation measures RMH’s audit committee has directed management to escalate the matter with both banks’ relationship managers on a daily basis. In parallel, management is preparing alternative audit evidence, such as bank statements or legal documents, should the formal confirmations remain delayed. Dr. Loh’s legal advisers are finalising a waiver letter to expedite the removal of guarantees once bank approvals are secured.

Operating update Core medical operations continue, with management focusing on cost controls and higher asset-use efficiency. The capital reorganisation completed on 30 October 2025 has preserved financial flexibility, enabling potential equity or debt fundraising to sustain operations and demonstrate compliance with GEM Rule 17.26.

Trading status Trading in RMH shares has been suspended since 1 April 2026 and will remain halted until the 2025 annual results are published and all resumption conditions are met. The board will issue further quarterly progress reports and material updates as necessary.

Shareholders and potential investors are advised to exercise caution when dealing in RMH securities.